Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

CSE/PHRM stock hub

CSE/PHRM has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

CSE/PHRMis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

6.8M

Canadian Securities Exchange

Market data

Live price

Current market quote for this ticker.

Current price

CSE/PHRM

In the news

Latest news · CSE/PHRM

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 11P50 15.6P75 25.4

Trailing P/En/a

P25 7.4P50 15.6P75 34.3

ROE-125.4

P25 -121.5P50 -40.9P75 0.5

ROIC-87.1

P25 -72.5P50 -16P75 1.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All CSE/PHRM market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

135

Groups with data

Currency

CAD

Showing 135 of 135 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Canada
Country code	CA
Enterprise value	CAD 6M
Exchange	Canadian Securities Exchange
Financial currency	CAD
First seen	2026-05-10
Industry	Biotechnology
Isin	CA71716H1082
Last refreshed	2026-05-10
Market cap	CAD 6.8M
Price	CAD 0.08
Price currency	CAD
Sector	Healthcare
Sic	2834
Symbol	cse/PHRM
Website	https://www.pharmather.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-16.1%
EV Earnings	-5.43x
P/B ratio	12.79x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	CAD -1.1M
Net Income Growth Quarters	2%
Net Income Growth Years	2%
ROA	-59.15
Roa5y	-38.66
ROCE	-229.1
ROE	-125.4
Roe5y	-40.73
ROIC	-87.14

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-64.31%
Cagr3y	-15.65%
Cagr5y	-20.76%
EPS Growth Years	2
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	CAD 1.1M
Cash	CAD 861,471
Current Assets	CAD 869,778
Current Liabilities	CAD 529,064
Equity	CAD 533,527
Liabilities	CAD 529,064
Long Term Assets	CAD 192,813
Long Term Liabilities	CAD 0
Net Cash	CAD 861,471
Net Cash By Market Cap	CAD 12.62
Net Cash Growth	-33.32%
Net Debt Equity	CAD -1.61
Tangible Book Value	CAD 533,527
Tangible Book Value Per Share	CAD 0.01
WACC	19.44

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.64
Net Working Capital	CAD -520,757
Quick ratio	1.64
Working Capital	CAD 340,714

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-2.06%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-64.29%
200-day SMA	0.19
3Y total return	-40%
50-day SMA	0.08
50-day SMA vs 200-day SMA	50under200
5Y total return	-68.75%
All Time High	1.24
All Time High Change	-93.95%
All Time High Date	2021-07-26
All Time Low	0.05
All Time Low Change	50%
All Time Low Date	2020-11-04
ATR	0.01
Beta	2.76
Beta1y	-1.36
Beta2y	-0.32
Ch YTD	-28.57
High	0.08
High52	0.77
High52 Date	2025-08-11
High52ch	-90.26%
Low	0.07
Low52	0.06
Low52 Date	2026-04-15
Low52ch	25%
Ma50ch	-3.6%
Price vs 200-day SMA	-60.61%
RSI	45.41
RSI Monthly	41.2
RSI Weekly	37.28
Sharpe ratio	-0.01x
Sortino ratio	0.03
Total Return	-2.06%
Tr YTD	-28.57
Tr1m	25%
Tr1w	-11.76%
Tr3m	-6.25%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CAD -1.2M

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	73,506,065%
Shares Insiders	19.1%
Shares Institutions	0.05%
Shares Out	91,019,065
Shares Qo Q	0%
Shares Yo Y	2.06%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	314,378.55x
Bv Per Share	0.01
Ch1m	25
Ch1w	-11.76
Ch1y	-64.29
Ch3m	-6.25
Ch3y	-40
Ch5y	-68.75
Ch6m	-42.31
Change	0%
Change From Open	7.14
Close	0.08
Days Gap	-6.67
Dollar Volume	3,000
Earnings Date	2026-05-14
EBIT	CAD -1.2M
EPS	CAD -0.01
F Score	1
Financing CF	250,000
Fiscal Year End	May
Founded	2,019
Is Primary Listing	1
Last Earnings Date	2026-01-26
Last Report Date	2026-02-28
Ma150	0.11
Ma150ch	-32.8%
Ma20	0.08
Ma20ch	-10.18%
Net CF	-430,438
Next Earnings Date	2026-05-14
Open	0.07
Position In Range	100
Price Date	2026-05-08
Ptbv Ratio	12.79
Relative Volume	0.13x
Share Based Comp	162,757
Tr6m	-42.31%
Volume	40,000

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does CSE/PHRM pay a dividend?

Capital-return profile for this ticker.

Performance

CSE/PHRM stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns CSE/PHRM?

Insider, institutional, and short-interest positioning.

Institutional ownership

+0.1%

Share of float held by funds and institutions

Insider ownership

+19.1%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+2.1%

Negative means the company is buying back shares.

Technical

CSE/PHRM momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

45.4

Neutral momentum band

Price vs 200-day MA

-60.6%

50/200-day relationship not available

Beta (5Y)

2.76

More volatile than the market

Sharpe ratio

-0.01

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About CSE/PHRM

Hub-level FAQ points readers to the deeper analysis pages.

What is the current cse/PHRM stock rating?

cse/PHRM is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full cse/PHRM analysis?

The full report lives at /stocks/cse/PHRM/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for cse/PHRM?

The latest report frames cse/PHRM around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the cse/PHRM page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.